¸ð½Ã´Â±Û ÇÁ·Î±×·¥ ÃÊ·ÏÁ¢¼ö »çÀüµî·Ï ¹ßÇ¥ÀÚ ¾È³» ¹ßÇ¥ÀÚ ¾È³» Çà»çÀå¾È³» ¼÷¹Ú¾È³» Ȩ

2008³âµµ Á¦ 94Â÷ ´ëÇÑ»êºÎÀΰúÇÐȸ Çмú´ëȸ ÃÖ¿ì¼ö³í¹®»ó ¼ö»óÀÚ·Î ¼±Á¤µÇ½ÉÀ» Áø½ÉÀ¸·Î ÃàÇϵ帳´Ï´Ù.
ÃÖ¿ì¼ö ³í¹®»ó ¼ö»óÀÚ ¸í´Ü°ú °­¿¬½Ã°£Àº ´ÙÀ½°ú °°À¸´Ï Âü°íÇÏ¿© Áֽñ⠹ٶø´Ï´Ù.

=== ´Ù À½ ===

ACCUVIX »ó
  • ºÐ¾ß : ¸ðüžÆÀÇÇÐ
  • ¼º¸í : ¹ÚÁ߽Š(¼­¿ïÀÇ´ë)
  • Á¦¸ñ : Measurement of Placental Alpha-Microglobulin-1 in Cervicovaginal Discharge to Diagnose Rupture of Membranes
  • °ÔÀçÁö : Obstetrics & Gynecology
ASTRA ZENECA »ó
  • ºÐ¾ß : »ý½Ä³»ºÐºñÇÐ
  • ¼º¸í : ±è¼ºÈÆ (¿ï»êÀÇ´ë)
  • Á¦¸ñ : Association between susceptibility to advanced stage endometriosis and the genetic polymorphisms of aryl hydrocarbon receptor repressor and glutathione-S-transferase T1 genes
  • °ÔÀçÁö : Human Reproduction
Çѱ¹¿©¼º¾Ï¿¬±¸Àç´Ü »ó
  • ºÐ¾ß : ºÎÀÎÁ¾¾çÇÐ
  • ¼º¸í : ±èº´±â (¼º±Õ°üÀÇ´ë)
  • Á¦¸ñ : Phase II study of consolidation chemotherapy after concurrent chemoradiation in cervical cancer: preliminary results
  • °ÔÀçÁö : International Journal of Radiation Oncology * Biology * Physics
Bayer Schering Pharma, Gynecare »ó
  • ºÐ¾ß : ÀϹݺÎÀΰúÇÐ
  • ¼º¸í : À¯ÀºÈñ (°æÈñÀÇ´ë)
  • Á¦¸ñ : Predictors of leiomyoma recurrence after laparoscopic myomectomy
  • °ÔÀçÁö : Journal of minimally invasive gynecology

= 9¿ù 26ÀÏ (±Ý) °­¿¬½Ã°£ =

ACCUVIX »ó 09:20~09:25   ¸ðüžÆÀÇÇÐ ¹ÚÁ߽Š(¼­¿ïÀÇ´ë)
ASTRA ZENECA »ó 09:25~09:30   »ý½Ä³»ºÐºñÇÐ ±è¼ºÈÆ (¿ï»êÀÇ´ë)
Çѱ¹¿©¼º¾Ï¿¬±¸Àç´Ü »ó 09:30~09:35   ºÎÀÎÁ¾¾çÇÐ ±èº´±â (¼º±Õ°üÀÇ´ë)
Bayer Schering Pharma, Gynecare »ó 09:35~09:40   ÀϹݺÎÀΰúÇÐ À¯ÀºÈñ (°æÈñÀÇ´ë)